The Global Veterinary Dermatology Drugs Market is Predict to reach $13.6 Billion by 2027, at a CAGR of 8.2%

Veterinary Dermatology Drugs Market Growth, Trends and Report Highlights

According to a new report Global Veterinary Dermatology Drugs Market, published by KBV research, The Global Veterinary Dermatology Drugs Market size is expected to reach $13.6 billion by 2027, rising at a market growth of 8.2% CAGR during the forecast period.

In 2020, the livestock animal segment acquired the significant revenue share. In addition, the segment is further segregated into cattle and others. Factors such as massive demand for animal protein and the occurrence of parasitic diseases in livestock animals are responsible for the growth of this segment. The cattle segment is likely to showcase the fastest growth rate during the forecast period.

In 2020, the oral segment garnered the maximum revenue share in the veterinary dermatology drugs market. Factors such as the massive availability of oral drugs in the form of tablets, feed additives, and pills are responsible for the growth of this segment. Moreover, market players are taking many initiatives associated with the oral route of administration which is likely to propel the growth of this segment.

APAC region is likely to show a promising growth rate during the forecast period. Factors like an increase in demand for veterinary dermatology drugs and increased awareness about the availability of these products in developing countries like India and China are expected to boost the regional market during the forecasting period. Moreover, as APAC region has the presence of many manufacturing units of key market players like Elanco, which would further propel the growth of the regional market.

Full Report: https://www.kbvresearch.com/veterinary-dermatology-drugs-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Merck Group, Elanco Animal Health, Inc., Zoetis, Inc., Eli Lilly and Company, Boehringer Ingelheim International GmbH, Vetoquinol SA (Soparfin SCA), Virbac, Bioibérica, S.A.U., Bimeda, Inc., and Ceva Santé Animale.

Global Veterinary Dermatology Drugs Market Segmentation

By Route of Administration

• Topical
• Injectable
• Oral

By Distribution Channel

• Retail
• Hospital Pharmacies
• Online

By Drug Indication

• Parasitic Infections
• Allergic Infections
• Other Indications

By Animal Type

• Companion Animal
• Livestock Animal

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled

• Merck Group
• Elanco Animal Health, Inc.
• Zoetis, Inc.
• Eli Lilly and Company
• Boehringer Ingelheim International GmbH
• Vetoquinol SA (Soparfin SCA)
• Virbac
• Bioibérica, S.A.U.
• Bimeda, Inc.
• Ceva Santé Animale

Related Reports:

North America Veterinary Dermatology Drugs Market Size, 2027

• November-2021
• 82 Pages

LAMEA Veterinary Dermatology Drugs Market Size Report, 2027

• November-2021
• 92 Pages

Europe Veterinary Dermatology Drugs Market Size Report, 2027

• November-2021
• 94 Pages

Asia Pacific Veterinary Dermatology Drugs Market Size, 2027

• November-2021
• 95 Pages